NangioTx Inc.

Making new highways for blood flow.

  • Stage Prototype Ready
  • Industry Nanotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded August 2015
  • Employees 5
  • Incorporation Type C-corp
  • Website nangiotx.com

Company Summary

NangioTx patented a peptide drug that generates new blood vessels in ischemic muscle, to treat Peripheral Artery Disease (PAD). It affects 8 MM individuals in the USA. Preclinical efficacy of V-10 has been shown in an acute hind-limb ischemia model in mice. A patent has been granted - U.S. Utility App. 14/454,802. 2014.

Team

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free